Ispectamab debotansine | Interleukin Related interleukin-related.com

Product Name :
Ispectamab debotansine

Search keywords :
Debotansine

drugId :
null

Target Vo:
B-cell maturation protein

Target Vo Short Name :
BCMA

Moa_Name:
B-cell maturation protein inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Celgene Corp

Active Company_Name :
Celgene Corp

Active Indication_Name:
Multiple Myeloma

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 1 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Enoblituzumab Protocol
Phospho-Hsp27 (Ser78) Rabbit pAb Epigenetic Reader Domain
c-Kit Antibody (YA502): c-Kit Antibody (YA502) is a non-conjugated and Rabbit origined monoclonal antibody about 110 kDa, targeting to c-Kit. It can be used for WB,IHC-P assays with tag free, in the background of Human.

Author: Interleukin Related

Related Posts